Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 21 - 30 of 83 opportunities
University of Edinburgh researchers have developed a unique range of research-grade reagents for studying plant cell walls. These tools are important in improving and developing new plant-based products and in the use of biomass for biofuels.
This collection of high quality malaria research materials and reagents will help researchers understand malaria and develop new diagnostic and therapeutic approaches to tackling it.
These compounds promote the regeneration of motor neurons in a Zebrafish spinal cord lesion assay, which provides a therapeutic for a range of motor neuron diseases, such as Amyotrophic Lateral Sclerosis.
An effective software tool for guiding diagnosis and fault finding in present instances by identifying patterns and knowledge implicit in historic information databases.
Glasgow researchers have validated that the 5HT1B receptor is a target for a miRNA in human pulmonary artery smooth muscle cell systems. miRNA are a new candidate drug class, which hold great promise for the treatment of Pulmonary Arterial Hypertension (PAH).
Researchers at the University of Glasgow have developed assays to screen against inflammation and type II diabetes.
An isothermal approach that has demonstrated reversibility using electrochemical control for denaturation and hybridysation of double stranded DNA/RNA for point-of-care diagnostics.
Researchers at the University of Dundee have developed a novel “intelligent” RFA device for destroying solid tumours in situ. This new concept in RFA treatment overcomes the limitations of current technology by providing a safe, versatile and highly effective method for complete tumour ablation ther...
Researchers at the University of Dundee have established
a novel transgenic mouse model suitable for the preclinical discovery of compounds for filaggrin-based disorders.
Targeted or localised drug delivery has long been the major goal of chemotherapy as it provides a more aggressive administration of substance directly to a tumour without the associated systemic side effects. Magnetic Resonance Imaging (MRI), has revolutionised this area of cancer treatment, providi...